Published in Int J Obes Relat Metab Disord on April 01, 2001
Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology (2014) 1.93
Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum. J Neurosci (2010) 1.18
The use of sibutramine in the management of obesity and related disorders: an update. Vasc Health Risk Manag (2009) 1.09
A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology (2008) 1.03
Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women. Nutr Res (2010) 0.95
Predictors of weight loss and maintenance in patients treated with antiobesity drugs. Diabetes Metab Syndr Obes (2011) 0.92
A two-year clinical lifestyle intervention program for weight loss in obesity. Food Nutr Res (2008) 0.88
Very low calorie diet (VLCD) followed by a randomized trial of corset treatment for obesity in primary care. Scand J Prim Health Care (2010) 0.88
Readiness redefined: a behavioral task during screening predicted 1-year weight loss in the look AHEAD study. Obesity (Silver Spring) (2013) 0.80
Do women with pelvic floor dysfunction referred by gynaecologists and urologists at hospitals complete a pelvic floor muscle training programme? A retrospective study, 1992-2008. Int Urogynecol J (2013) 0.79
Rate of weight loss can be predicted by patient characteristics and intervention strategies. J Acad Nutr Diet (2011) 0.79
Sibutramine and the sympathetic nervous system in obese humans. Clin Auton Res (2005) 0.78
High-Intensity Interval Training in Normobaric Hypoxia Improves Cardiorespiratory Fitness in Overweight Chinese Young Women. Front Physiol (2017) 0.78
Effects of sibutramine and rimonabant in rats trained to discriminate between 22- and 2-h food deprivation. Psychopharmacology (Berl) (2008) 0.77
Taking Orlistat: Predicting Weight Loss over 6 Months. J Obes (2010) 0.75
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord (2000) 6.25
Who succeeds in maintaining weight loss? A conceptual review of factors associated with weight loss maintenance and weight regain. Obes Rev (2005) 5.72
Executive summary: Foresight 'Tackling Obesities: Future Choices' project. Obes Rev (2007) 5.35
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Flaws in methods of evidence-based medicine may adversely affect public health directives. Surgery (2005) 3.49
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest (1998) 3.18
The predictive validity of body mass index based on self-reported weight and height. Int J Obes (1989) 2.65
Clinical significance of adaptive thermogenesis. Int J Obes (Lond) (2007) 2.53
A randomized trial of the effects of dietary counseling on gestational weight gain and glucose metabolism in obese pregnant women. Int J Obes (Lond) (2008) 2.52
Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord (1999) 2.43
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Reduced food intake after jejunoileal bypass: a possible association with prolonged gastric emptying and altered gut hormone patterns. Am J Clin Nutr (1997) 2.27
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev (1995) 2.13
Assessing the impact of complications on the costs of Type II diabetes. Diabetologia (2002) 2.11
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) (2011) 2.08
The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction. Int J Obes Relat Metab Disord (2001) 2.05
High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. Diabetes Care (2000) 2.04
[New discoveries about the cause of diabetes. Type 2 diabetes mellitus changed to "obesity-dependent diabetes mellitus"]. Ugeskr Laeger (2001) 2.02
Quality of alternative medicine--complications and avoidable deaths. Qual Assur Health Care (1990) 2.00
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab (2001) 1.97
Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ (1996) 1.90
Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr (1994) 1.90
Physicians promoting bicycle helmets for children: a randomized trial. Am J Public Health (1991) 1.90
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia (2012) 1.85
Long-term cost-effectiveness of weight management in primary care. Int J Clin Pract (2010) 1.81
Urethral insertion of foreign bodies. A report of contagious self-mutilation in a maximum-security hospital. Arch Gen Psychiatry (1982) 1.80
Effect of normal-fat diets, either medium or high in protein, on body weight in overweight subjects: a randomised 1-year trial. Int J Obes Relat Metab Disord (2004) 1.79
Weight development over time in parous women--the SPAWN study--15 years follow-up. Int J Obes Relat Metab Disord (2003) 1.78
Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'? Obes Rev (2000) 1.76
Modern sedentary activities promote overconsumption of food in our current obesogenic environment. Obes Rev (2011) 1.75
Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr (1999) 1.73
Diagnosing growth-hormone deficiency in adults. Lancet (1994) 1.73
Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia (1994) 1.73
Maternal body weight development after pregnancy. Int J Obes (1990) 1.72
Term infants with hypoxic-ischemic encephalopathy: outcome at 3.5 years. Dev Med Child Neurol (1985) 1.69
A simple test for autonomic neuropathy in juvenile diabetics. Acta Med Scand (1979) 1.67
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord (2001) 1.65
Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2004) 1.63
Night eating and nocturnal eating-two different or similar syndromes among obese patients? Int J Obes Relat Metab Disord (2001) 1.63
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord (2003) 1.58
Weight maintenance after a very low calorie diet (VLCD) weight reduction period and the effects of VLCD supplementation. A prospective, randomized, comparative, controlled long-term trial. J Intern Med (1995) 1.58
Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial. Int J Clin Pract (2009) 1.58
Long-term effects of a very low calorie diet (Nutrilett) in obesity treatment. A prospective, randomized, comparison between VLCD and a hypocaloric diet+behavior modification and their combination. Int J Obes Relat Metab Disord (1997) 1.58
Empowering primary care to tackle the obesity epidemic: the Counterweight Programme. Eur J Clin Nutr (2005) 1.57
Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol (1985) 1.56
Inhibition of heterologous strains of HIV by antisense RNA. AIDS (1991) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Trends in eating patterns, physical activity and socio-demographic factors in relation to postpartum body weight development. Br J Nutr (1994) 1.54
Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis Cartilage (2005) 1.53
Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev (2000) 1.53
Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (1995) 1.48
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
Leptin is influenced both by predisposition to obesity and diet composition. Int J Obes Relat Metab Disord (2000) 1.46
Cimetidine suspension as adjuvant to energy restricted diet in treating obesity. BMJ (1993) 1.44
How does the body deal with energy from alcohol? Nutrition (2001) 1.44
[Inter-disciplinary European guidelines on surgery of severe obesity]. Vnitr Lek (2008) 1.42
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord (1999) 1.41
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41
The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries - a comprehensive design for long-term intervention. Obes Rev (2009) 1.40
Place of obesity clinics in the NHS. Br J Hosp Med (1993) 1.39
Obesity treatment and attrition: no relationship to obesity level. Obes Res (1996) 1.39
The good and the bad news: surgery vs. drug therapy. Obes Rev (2008) 1.39
[The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial]. Ugeskr Laeger (1992) 1.38
Monitoring of celiac plexus block in chronic pancreatitis. Pain (1989) 1.37
Rating the appropriateness of coronary angiography, coronary angioplasty and coronary artery bypass grafting: the ACRE study. Appropriateness of Coronary Revascularisation study. J Public Health Med (1999) 1.36
Long-term weight development after pregnancy. Obes Rev (2002) 1.35
Impact on weight dynamics and general growth of the common FTO rs9939609: a longitudinal Danish cohort study. Int J Obes (Lond) (2008) 1.34
Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med (2009) 1.33
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia (2005) 1.33
Ephedrine-induced thermogenesis in man: no role for interscapular brown adipose tissue. Clin Sci (Lond) (1984) 1.32
Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr (2011) 1.32
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr (1998) 1.32
Effect of short-term high dietary calcium intake on 24-h energy expenditure, fat oxidation, and fecal fat excretion. Int J Obes (Lond) (2005) 1.30
Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr (1990) 1.29
Prevalence of obesity in Sweden. Obes Rev (2006) 1.28
An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod (1997) 1.28
Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev (2009) 1.27
Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies. Diabetes (1982) 1.26
Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol (1986) 1.26
Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity. J Clin Endocrinol Metab (2008) 1.25
Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol (1976) 1.25